Beaird Harris Wealth Management, LLC Indaptus Therapeutics, Inc. Transaction History
Beaird Harris Wealth Management, LLC
- $1.01 Billion
- Q2 2024
A detailed history of Beaird Harris Wealth Management, LLC transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Beaird Harris Wealth Management, LLC holds 300 shares of INDP stock, worth $351. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300Holding current value
$351% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INDP
# of Institutions
20Shares Held
600KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$299,8300.0% of portfolio
-
Investment House LLC Las Vegas, NV102KShares$119,8510.01% of portfolio
-
Geode Capital Management, LLC Boston, MA59.3KShares$69,3910.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$53,0430.02% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ44.1KShares$51,5790.01% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $9.66M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...